Hong Kong Stocks Decline on Renewed U.S.-China Friction; Shenzhen HQVT Technology Shines on Debut

MT Newswires Live
Jun 22

Hong Kong stocks fell on Monday as investors reacted to unchanged Chinese lending rates and renewed U.S.-China tensions after Beijing imposed export controls on several American entities.

The Hang Seng Index fell 0.7%, or 156.29 points, to close at 23,768.52, while the Hang Seng China Enterprises Index dropped 0.8%, or 61.30 points, to finish at 7,914.74.

The People's Bank of China kept the one-year loan prime rate, the benchmark for most corporate and household loans, at 3.00%, while the five-year rate, a reference for mortgage lending, remained at 3.50%.

Meanwhile, China's Commerce Ministry added 10 U.S. entities to its export control list, immediately banning exports of dual-use items to those companies. The ministry said the measures were taken to safeguard national security and interests, describing them as a response to what it called the U.S. government's "malicious practices."

The move followed Washington's recent decision to add several Chinese companies to a military-related entity list.

In corporate news, Shenzhen HQVT Technology (HKG:1392) made its Hong Kong debut, closing nearly 271% higher at HK$26.70, compared with its offer price of HK$7.20.

Insilico Medicine (HKG:3696) closed over 4% higher after entering a neuroimmune drug discovery collaboration with SK Biopharmaceuticals (KRX:326030), with the deal carrying a potential value of more than $2.5 billion.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10